Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;30(7):959-65.
doi: 10.1007/s10067-011-1709-2. Epub 2011 Feb 22.

Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis

Affiliations

Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis

Chih-Te Charles Wu et al. Clin Rheumatol. 2011 Jul.

Abstract

Heat shock protein (Hsp) 60 has been implicated in the pathogenesis of various inflammatory and autoimmune diseases. This study aimed to investigate synovial fluid and serum concentrations of Hsp60 and anti-Hsp60 and their relationship with juvenile idiopathic arthritis (JIA). Forty-eight patients with JIA, including 22 oligo-articular, 19 poly-articular, and 7 systemic diseases, and 33 normal controls were enrolled in this study. Synovial fluid and serum Hsp60 and anti-Hsp60 concentrations were measured via ELISA. Serum concentrations of Hsp60 of active and inactive oligo- and poly-articular JIA were significantly higher than those of normal controls. Serum concentration of anti-Hsp60 in active oligo-articular JIA was higher than that of normal controls (49.25 vs. 35.76 ng/mL, p = 0.059). Similarly, serum concentration of anti-Hsp60 in active poly-articular JIA was significantly higher than that of inactive samples (65.05 vs. 26.54 ng/mL, p = 0.008). In addition, serum concentration of Hsp60 correlated with the time required for remission from flare-ups in patients with JIA. Serum concentration of Hsp60 correlated well with time required for remission from flare-ups in patients with JIA, representing a potential disease marker to monitor disease activity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int Immunol. 2006 Apr;18(4):573-80 - PubMed
    1. J Immunol. 1999 Apr 1;162(7):3757-60 - PubMed
    1. Chang Gung Med J. 2001 Feb;24(2):77-83 - PubMed
    1. FASEB J. 2003 Aug;17(11):1567-9 - PubMed
    1. Cell. 2006 May 5;125(3):443-51 - PubMed

Publication types

LinkOut - more resources